Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Codon-Optimized Gene Construct Design

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, issued by the NIH NCI under the Department of Health and Human Services, involves the design and generation of a codon-optimized gene expression cassette. The project specifically focuses on encoding the mouse tumor antigen gp70 fused with the invariant chain (Ii), ensuring compatibility with MVA and ChAdOx-1 viral vector systems for expression in mouse cells. The opportunity was posted on August 17, 2026, with a response deadline of August 24, 2026. The work is designated under NAICS code 541715 and is set to be performed in Oxford, OX3 7DQ.

General Info

NIH NCI subcontract for codon-optimized gp70-Ii gene expression cassettes in Oxford, UK.

Agency

Department Of Health And Human Services → NIH NciView Agency

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)View NAICS

Place of Performance

Oxford, GB-OXF, OX3 7DQ, GBR

Set-Aside

NONE

Documents

This scope was carved out of 75N98026Q00996.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → NIH Nci
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → NIH Nci
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Design and generate a codon-optimized gene expression cassette encoding mouse tumor antigen gp70 fused with invariant chain (Ii), compatible with ChAdOx-1 and MVA viral vector systems for mouse cell expression.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
Army Contracting Command – Red River Army Depot (ACC-RRAD) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911RQ-26-S-C001
The U.S. Army, through the Army Contracting Command – Red River Army Depot, is pursuing the modernization of its Organic Industrial Base under Commercial Solutions Opening W911RQ-26-S-C001, a flexible procurement initiative authorized under DFARS Subpart 212.70 and administered under FAR Part 12 Commercial Item Procedures. This effort is aligned with the Army’s strategic focus on Convergent Manufacturing, integrating advanced technologies such as digital twin, automation, connected digital enterprise, and cybersecurity to enhance producibility, sustainment, and logistics capabilities. The solicitation invites innovative commercial solutions across multiple areas of interest including automated media blast systems, camera monitoring for vehicle test tracks, power pack interface and test sets, AS9100 certification support, track pin and bushing manufacturing, and fixture removal for Bradley Fighting Vehicle hulls. Each area of interest is evaluated independently with specific submission deadlines, and all responses must be submitted electronically via email in two separate volumes: a technical proposal excluding cost data and a price proposal with full cost breakdowns, including labor rates, material quotes, and overhead. Offers must be unclassified, submitted through SAM.gov-registered entities with a Unique Entity ID, and adhere to strict formatting rules including a maximum of five pages or fifteen slides for initial solution briefs. Evaluation of proposals prioritizes technical merit and feasibility, followed by industrial base impact, speed and scalability of implementation, price fairness and reasonableness, private investment leverage, and a credible transition plan to full production. The government will use a trade-off approach rather than lowest price technically acceptable, with no numerical weights assigned but clear emphasis on non-price factors. Awards are contingent upon funding availability, successful negotiation, and technical validation, and do not obligate the government to proceed with any contract until formal award. Performance is expected to occur at Red River Army Depot in Texarkana, Texas, with inspection and acceptance conducted by the government at that location per MIL-DTL-11891, MIL-STD-1907, ASTM, and other referenced standards covering material quality, inspection, and manufacturing processes. Contractors must register in Wide Area Work Flow for invoicing, and proposals must comply with secure-by-design principles and modular open systems architecture requirements. No contract clauses, special requirements, or detailed packaging and marking specifications are provided in the solicitation, leaving these to be defined during contract negotiation post-selection. All submissions must be received by 5:00 P.M. CDT on their respective
W6QK Acc Rrad

POSTED

about 19 hours ago

DEADLINE

in about 1 month
View Details

More opportunities from Department Of Health And Human Services → NIH Nci

Same awarding agency

NAICS: 54171
Federal
NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM
Solicitation # 75N98026R00109
The National Cancer Institute (NCI) is soliciting Phase I Small Business Innovation Research (SBIR) proposals under the Innovative Concept Award Program to advance research and development in therapeutic or preventative technologies, and devices, diagnostic tools, or digital health solutions for pediatric cancers and rare cancers, particularly those with a 5-year survival rate below 50%. This solicitation, numbered 75N98026R00109, is a total small business set-aside under FAR 19.5 with a NAICS code of 54171 and is open exclusively to small business concerns registered in the System for Award Management (SAM) and the SBA Company Registry, with a valid Unique Entity Identifier. Proposals must demonstrate scientific merit without requiring preliminary data, but must clearly articulate an unmet clinical need, the targeted cancer type, a viable development path, and a plan to generate initial proof-of-concept data through well-reasoned experiments. The base R&D budget is $300,000, with an optional additional $6,500 available for technical and business assistance, resulting in a potential contract value of up to $306,500. Amendments to the original solicitation have removed all requirements related to the Data Management and Sharing Plan in Sections 5.9, 6.1, and 8.5, while all other terms, conditions, and submission deadlines remain unchanged. The proposal deadline is September 21, 2026, at 5:00 p.m. Eastern Daylight Time, and submissions must be made electronically via the eCPS portal as a three-part package: a single PDF Technical Proposal including the required form and NIH biosketches, a completed Human Subjects and Clinical Trials Information Form (even if no human subjects are involved), and a single PDF Business Proposal with pricing details. Evaluation will assess technical acceptability, scientific rationale, and security risk as pass/fail gates, followed by a second review by NCI program staff. Contract administration requires electronic funds transfer for payment, mandatory SAM registration as a prerequisite for payment, and compliance with Section 508 for electronic reporting. Non-exempt human subjects research is prohibited, and all contractors must comply with human subjects protection regulations as outlined in 45 CFR part 46, maintain an active Federal-wide Assurance, and adhere to ethics, equal opportunity, E-Verify, and patent infringement reporting requirements. All awards are contingent on funding availability

POSTED

8 days ago

DEADLINE

in about 1 month
View Details